Helen S. Kim

Helen S. Kim is recorded as Board Member at Prothena Corp Public Ltd Co (PRTA) and Board Member at Assembly Biosciences, Inc. (ASMB) since June 11, 2020. The newest filing on record that lists Helen S. Kim as Board Member at Prothena Corp Public Ltd Co (PRTA) is dated October 7, 2025. Helen S. Kim was last confirmed as Board Member at Exicure, Inc. (XCUR) in a filing dated April 21, 2020. Aktis Oncology, Inc. reported in an 8-K filed April 16, 2026 that Helen S. Kim resigned as member of the Board and all committees thereof, effective May 20, 2026. Prothena Corp Public Ltd Co reported in an 8-K filed September 1, 2022 that Helen S. Kim was appointed director, effective August 30, 2022. Assembly Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Prothena Corp Public Ltd Co is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Assembly Biosciences, Inc. includes Jason A. Okazaki (CEO, COO and Board Member), John G. McHutchison, A.O., M.D. (Chairman and Board Member), Jeanette M. Bjorkquist (CFO) and 7 others.